CRON peer analysis
Cronos (CRON) against its competitors: price, today's move, 1-year return and market value side by side.
CRON and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | $29.45 | 5.10% | 16.59% | $1.19B |
| BBOT BridgeBio Oncology | $2.19 | -4.78% | -81.90% | – |
| COLL Collegium | $25.19 | 6.42% | -29.56% | $770.59M |
| EMBC Embecta | $6.33 | -2.91% | -53.18% | – |
| IRMD iRadimed | $84.52 | -4.58% | -2.55% | $1.13B |
| NRIX Nurix Therapeutics | $14.95 | -6.27% | 21.94% | – |
| PCRX Pacira BioSciences | $36.44 | 0.11% | 62.39% | $1.45B |
| PHAT Phathom Pharmaceuticals | $5.07 | -10.83% | -62.45% | $461.74M |
| RAPP Rapport Therapeutics | $23.70 | -8.60% | -11.07% | – |
| XNCR Xencor | $34.05 | -2.81% | 148.50% | $2.60B |
| CRON Cronos | $3.69 | 5.13% | 50.61% | $1.29B |
- CRON's peers: AMPH (Amphastar Pharmaceuticals), BBOT (BridgeBio Oncology), COLL (Collegium), EMBC (Embecta), IRMD (iRadimed), NRIX (Nurix Therapeutics), PCRX (Pacira BioSciences), PHAT (Phathom Pharmaceuticals).
Updated 2026-11-06 07:49 UTC